Fulltext
The full text is available in PDF.
International Cardiovascular Research Journal
The Official Annually Journal of Cardiovascular Research Center, Shiraz University of Medical Sciences
Outlines
Safety of enoxaparin versus unfractioned heparin in patients undergoing percutaneous coronary intervention using drug eluting stents: A pilot study
Author(s):
1Cardiovascular Research Center, Shiraz University of Medical Science, Shiraz, Iran
Published online:Sep 30, 2007
Article type:Research Article
Received:May 22, 2018
Accepted:Sep 30, 2007
How to Cite:Zibaeenezhad MJ, Kamfiroozi H, Aghasadeghi K. Safety of enoxaparin versus unfractioned heparin in patients undergoing percutaneous coronary intervention using drug eluting stents: A pilot study. Int Cardiovasc Res J. 2018;1(3):e79524. doi:
Abstract
Keywords
References
- 1.The references are available in PDF.
Copyright
© 2018, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
19
Apr
2022
Efficacy and Safety of Two Different Enoxaparin Doses for Thromboprophylaxis in Non-critically Ill Patients: A Randomized Controlled Trial
Ilad Alavi-Darazam,
Kimia Forouhar,
Omid Moradi,
Ali Saffaei,
Sara Asadi,
Zahra Sahraei
Alavi-Darazam I, Forouhar K, Moradi O, Saffaei A, Asadi S, et al. Efficacy and Safety of Two Different Enoxaparin Doses for Thromboprophylaxis in Non-critically Ill Patients: A Randomized Controlled Trial. Iran J Pharm Res. 2022;21(1):e126555. doi: https://doi.org/10.5812/ijpr-126555
30
Sep
2014
New Oral Anticoagulants in Acute Coronary Syndrome: Is There Any Advantage Over Existing Treatments?
Andrea Messori,
Valeria Fadda,
Roberta Gatto,
Dario Maratea,
Sabrina Trippoli
Messori A, Fadda V, Gatto R, Maratea D, Trippoli S. New Oral Anticoagulants in Acute Coronary Syndrome: Is There Any Advantage Over Existing Treatments?. Int Cardiovasc Res J. 2017;8(3):e11104. doi:
11
Apr
2022
Enoxaparin in the Prevention of Deep Vein Thrombosis in Patients with Acute Ischemic Stroke
Khanh Nguyen Duy,
Diem Thi Nguyen,
Minh Van Le,
Long Duy Le,
Huy Cong Tran,
Nhan Huu Kha
,et al.Duy KN, Nguyen DT, Le MV, Le LD, Tran HC, et al. Enoxaparin in the Prevention of Deep Vein Thrombosis in Patients with Acute Ischemic Stroke. J Adv Immunopharmacol. 2022;2(1):e122415. doi: https://doi.org/10.5812/tms-122415
30
Jun
2009
Platelet GP IIb/IIIa Receptor Inhibition by Eptifibatide in non ST-elevation MI-Acute Coronary Syndrome
S Abdi,
M Momtahen,
F Javadzadeh,
BF Farsad,
AS Kazzazi,
, Sharifian
,et al.Abdi S, Momtahen M, Javadzadeh F, Farsad B, Kazzazi A, et al. Platelet GP IIb/IIIa Receptor Inhibition by Eptifibatide in non ST-elevation MI-Acute Coronary Syndrome. Int Cardiovasc Res J. 2009;3(2):e68402. doi:
30
Jun
2010
The Outcome of Six-month Clinical Trial with Eucatax Paclitaxel Eluting Stent Compared With Eucastsflex Bare Metal Stent in Patients Undergoing De Novo Coronary Stenting
Mohammad Ali Ostovan,
M Rezaie,
Javad Kojuri
Ostovan MA, Rezaie M, Kojuri J. The Outcome of Six-month Clinical Trial with Eucatax Paclitaxel Eluting Stent Compared With Eucastsflex Bare Metal Stent in Patients Undergoing De Novo Coronary Stenting. Int Cardiovasc Res J. 2010;4(2):e65013. doi:
Comments
Number of Comments:0Cited by
- Scopus by DOI: 0
Last Update: 2 weeks ago
- Scopus by Title: 0
Last Update: 2 weeks ago
- Scopus by Title (Ref): 0
Last Update: 2 weeks ago
- CrossRef: 0
Last Update: 4 days ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Search Relations
Author(s):
Related Articles